AI assistant
Sending…
Q/C TECHNOLOGIES, INC. — Director's Dealing 2024
May 16, 2024
35313_dirs_2024-05-16_b8b0dff2-33a6-4b23-89f4-c28daaa2ec01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MyMD Pharmaceuticals, Inc. (MYMD)
CIK: 0001321834
Period of Report: 2024-04-08
Reporting Person: Glass Mitchell (Director)
More from Q/C TECHNOLOGIES, INC.
Regulatory Filings
2026
Jul 2
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 29
Annual Report
2026
Apr 15
Capital/Financing Update
2026
Feb 11
Director's Dealing
2026
Jan 30
Director's Dealing
2026
Jan 30
Board/Management Information
2026
Jan 23
Regulatory Filings
2025
Dec 9
Capital/Financing Update
2025
Dec 1